The above experimental results demonstrate the function of IL-33 in the upregulation and downregulation of pathways in colorectal cancer, indicate the complexity of the role of IL-33, and provide a novel concept for further improving the function of IL-33 derivatives for tumor control. This evidence concerns the gene IL33 and colorectal cancer.